Structure Therapeutics In...
(GPCR) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
27.75
0.33%
After-hours Jan 03, 2025, 05:08 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Net Income | -89.62M | -51.32M | -38.05K | -15.88K |
Depreciation & Amortization | 295.00K | 277.00K | 72.00 | 20.03K |
Stock-Based Compensation | 8.19M | 2.51M | 1.49M | 570.00K |
Other Working Capital | 7.83M | 815.00K | 2.17K | -74 |
Other Non-Cash Items | -5.32M | -558.00K | 241.00 | 77.00 |
Deferred Income Tax | n/a | n/a | 27.00 | -20.03K |
Change in Working Capital | 6.97M | 2.97M | 4.06K | 946.00 |
Operating Cash Flow | -79.49M | -46.12M | -32.16K | -14.28K |
Capital Expenditures | -2.17M | -155.00K | -1.21K | -19 |
Acquisitions | n/a | 61.95K | -19.07K | n/a |
Purchase of Investments | -416.99M | -123.45M | -4.21K | -21.13K |
Sales Maturities Of Investments | 151.05M | 61.50M | 23.28K | n/a |
Other Investing Acitivies | -231.38K | -61.95K | 19.07K | -21.13K |
Investing Cash Flow | -268.34M | -62.11M | 17.86K | -21.15K |
Debt Repayment | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | -6.00K | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -20.77M | 29.02M | 103.25K | 25.84M |
Financial Cash Flow | 451.53M | 29.01M | 103.25K | 25.84K |
Net Cash Flow | 103.70M | -79.21M | 88.95K | -9.59K |
Free Cash Flow | -81.66M | -46.27M | -33.37K | -14.30K |